Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02233647 · ClinicalTrials.gov registry record · Early Phase 1
Phendimetrazine and Cocaine
A Early Phase 1 study, sponsored by William Stoops.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
NCT02233647 is a Early Phase 1 study that has completed, run by William Stoops. The registered enrollment target is 11 participants.
The verdict
NCT02233647, a Early Phase 1 study, has completed, sponsored by William Stoops.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
This study will determine the safety and tolerability of phendimetrazine (Bontril®) as a pharmacotherapy for cocaine use disorder. A rigorous, inpatient human laboratory study will be conducted in which the subjective and physiological effects of cocaine are evaluated during maintenance on placebo and phendimetrazine.
Interventions
- DRUG Placebo
- DRUG Cocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02233647
The ClinicalTrials.gov registry entry for NCT02233647 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is William Stoops, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02233647 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02233647 about?
NCT02233647 is a clinical study titled "Phendimetrazine and Cocaine". This study will determine the safety and tolerability of phendimetrazine (Bontril®) as a pharmacotherapy for cocaine use disorder. A rigorous, inpatient human laboratory study will be conducted in which the subjective and physiological effects of cocaine are evaluated during maintenance on placebo a...
What is the current status of trial NCT02233647?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2014-09. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02233647?
The interventions under investigation include: Placebo (DRUG), Cocaine (DRUG).
Who is sponsoring clinical trial NCT02233647?
This trial is sponsored by William Stoops, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.